Over the course of the past month, the Wesana Health Holdings Inc (OTCMKTS:WSNAF) stock has gone on a strong move and managed to deliver gains of as much as 22% to its investors.
The company, which is an emerging operator in the data driven life sciences space, was in focus last week after it announced that on September 8, 2021 it had been successful in completing the acquisition of Psychedelitech Inc. Psychedelitech is popularly known as PsyTech and the acquisition might bring the Wesana Health stock into fresh focus among investors.
The Chief Executive Officer of Wesana Health, Daniel Carcillo, spoke about the acquisition as well. He seemed to imply that the acquisition of PsyTech could be strategic importance for Wesana. Carcillo stated that PsyTech has been successful in the development of a platform that is meant for treating neurological issues and it is expected to significantly speed up the capabilities of Wesana.
He added that the platform could also help Wesana in hitting the market with its own products quickly. He went on to add that with this acquisition and the added strength of the PsyTech employees, Wesana is closer to hitting its goals in the field of neurological health.